Hemorrhagic vasculitis in an adolescent induced by the COVID-19 virus
DOI:
https://doi.org/10.15574/SP.2024.6(142).120126Keywords:
vasculitis, Genoch-Schoenlein purpura, children, meningococcal infection, COVID-19Abstract
Hemorrhagic vasculitis (Henoch-Schönlein purpura) Vasculitis is a common disease that is often preceded by a bacterial or viral infection of the upper respiratory tract.
Aim - to investigate the specifics of the course and treatment of hemorrhagic vasculitis in a child after suffering from COVID-19 on the example of a clinical case.
Clinical case. A case of acute hemorrhagic vasculitis in a 14-year-old boy is presented. A boy was admitted to Ternopil Regional Children's Clinical Hospital with complaints of a rise in body temperature to high numbers, the appearance of rashes on the lower limbs, buttocks, pain and swelling in the knee joints. From the anamnesis of life, it is known that 2 weeks before the appearance of this hemorrhagic syndrome, he suffered from COVID-19. The disease began acutely with an increase in temperature of 40.1°C. Specific disorders associated with vasculitis/capillaritis are considered in detail: clinical syndromes are identified during objective examination: intoxication, hemorrhagic, articular. Examinations were carried out: general blood test, general urine test, biochemical tests. Maintenance therapy with sufficient hydration, restoration and maintenance of electrolyte balance. In order to control pain, simple analgesics (paracetamol 15 mg/kg every 6 hours orally) were prescribed. A differential diagnosis was made with meningococcal infection, idiopathic arthritis, and thrombocytopenia. The algorithm for the diagnosis of hemorrhagic vasculitis is presented. The need to be vigilant about the development of hemorrhagic vasculitis in children who have suffered from COVID-19 is justified.
The research was carried out in accordance with the Declaration of Helsinki. Informed consent of the child's parents was obtained for the research.
No conflict of interests was declared by the authors.
References
AlGhoozi DA, AlKhayyat H M. (2020). A child with Henoch-Schonlein purpura secondary to a COVID-19 infection. BMI Case Report. 14(1): 239910. https://doi.org/10.1136/bcr-2020-239910; PMid:33408113 PMCid:PMC10577763
Andina D, Belloni Fortina A, Bodemer C et al. (2021). Skin manifestations of COVID-19 in children: Part 2. Clin Exp Dermatol. 46(3): 451-461. https://doi.org/10.1111/ced.14482; PMid:33166429 PMCid:PMC9275399
Becker RC. (2020). COVID-19 update: Covid-19-associated coagulopathy. J Thromb Thrombolysis. 50: 54-67. https://doi.org/10.1007/s11239-020-02134-3; PMid:32415579 PMCid:PMC7225095
Boyarchuk OR, Nykytyuk SO, Borys ZYa, Levenets SS, Shylo OR. (2022). Hepatic vein thrombosis in a child with COVID-19: clinical case Modern Pediatrics. Ukraine. 3(123): 94-99. https://doi.org/10.15574/SP.2022.123.94
Colling ME, Kanthi Y. (2020). COVID-19-associated coagulopathy: An exploration of mechanisms Vasc Med. 25(5): 471-478. https://doi.org/10.1177/1358863X20932640; PMid:32558620 PMCid:PMC7306998
De Perosanz-Lobo D, Fernandez-Nieto D, Burgos-Blasco P et al. (2020). Urticarial vasculitis in COVID-19 infection: a vasculopathy-related symptom?. J Eur Acad Dermatol Venereol. 34: 566-568. https://doi.org/10.1111/jdv.16713; PMid:32510648 PMCid:PMC7300972
Gaillard F, Ismael S, Sannier A. (2020). Tubuloreticular inclusions in COVID-19-related collapsing glomerulopathy.Kidney Int. 98: 241. https://doi.org/10.1016/j.kint.2020.04.022; PMid:32471641 PMCid:PMC7185005
Hasbani GE, Ali T. Taher AT, Jawad ASM et al. (2021). Henoch-Schönlein purpura: Another COVID-19 complication. Pediatric Dermatology. 8(5): 1359-1360. https://doi.org/10.1111/pde.14699; PMid:34272762
Iba T, Connors JM, Levy JH. (2020). The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res. 69(12): 1181-1189. https://doi.org/10.1007/s00011-020-01401-6; PMid:32918567 PMCid:PMC7486586
Jacobi M, Lancrei HM, Brosh-Nissimov T et al. (2021). Purpurona: A Novel Report of COVID-19-Related Henoch-Schonlein Purpura in a Child. Pediatr Infect Dis J. 40: 93-94. https://doi.org/10.1097/INF.0000000000003001; PMid:33201063
Jedlowski PM, Jedlowski M.F. (2022). Coronavirus disease 2019-associated immunoglobulin A vasculitis/Henoch-Schönlein purpura: A case report and review. The Journal of Dermatology. 49(1): 190-196. https://doi.org/10.1111/1346-8138.16211; PMid:34741345 PMCid:PMC8652426
Jones VG, Mills M, Suarez D et al. (2020). COVID-19 and Kawasaki disease: novel virus and novel case. Hosp Pediatr. 10: 537-540. https://doi.org/10.1542/hpeds.2020-0123; PMid:32265235
Kissling S, Rotman S, Gerber C. (2020). Collapsing glomerulopathy in a COVID-19 patient. Kidney Int. 98: 228-231. https://doi.org/10.1016/j.kint.2020.04.006; PMid:32471639 PMCid:PMC7156952
Larsen CP, Bourne TD, Wilson JD. (2020). Collapsing glomerulopathy in a patient with coronavirus disease 2019 (COVID-19). Kidney Int Rep. 5: 935-939. https://doi.org/10.1016/j.ekir.2020.04.002; PMid:32292867 PMCid:PMC7142700
Licciardi F, Pruccoli G, Denina M et al. (2020). SARS-CoV-2-induced Kawasaki-like hyperinflammatory syndrome: a novel COVID phenotype in children. Pediatrics. 146(2): 20201711. https://doi.org/10.1542/peds.2020-1711; PMid:32439816
Nykytyuk S, Levenets S, Horishnyi M et al. (2022). Awareness of lyme disease among vocational school students and children (Ternopil Region, Western Ukraine). Georgian Medical News. 24(4): 67-71.
Oni L, Sampath S. (2019). Childhood IgA Vasculitis (Henoch Schonlein Purpura) - Advances and Knowledge Gaps. Front Pediatr. 7: 257. https://doi.org/10.3389/fped.2019.00257; PMid:31316952 PMCid:PMC6610473
Peleg Y, Kudose S, D'Agati V. (2020). Acute kidney injury due to collapsing glomerulopathy following COVID-19 infection. Kidney Int Rep. 5: 940-945. https://doi.org/10.1016/j.ekir.2020.04.017; PMid:32346659 PMCid:PMC7186120
Riscassi S, Kalapurackal MA, Battisti L et al. (2022). Vasculitis in a Child with COVID-19: A Novel Presentation of Henoch-Schönlein Purpura. KlinPadiatr. 234(02): 116-118. https://doi.org/10.1055/a-1532-2243; PMid:34311476
Schvartz A, Belot A, Kone-Paut I. (2020). Pediatric Inflammatory Multisystem Syndrome and Rheumatic Diseases during SARS-CoV-2 Pandemic. Front Pediatr. 8: 605807. https://doi.org/10.3389/fped.2020.605807; PMid:33344389 PMCid:PMC7746854
Sharma A, Garcia G, Arumugaswami V, Svendsen CN. (2020) Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep Med. 1(4):100052. https://doi.org/10.1016/j.xcrm.2020.100052; PMid:32835305 PMCid:PMC7323681
Suso AS, Mon C, Oñate Alonso I et al. (2020). IgA Vasculitis with Nephritis (Henoch-Schönlein Purpura) in a COVID-19 Patient. Kidney Int Rep. 5(11): 2074-2078. https://doi.org/10.1016/j.ekir.2020.08.016; PMid:32839743 PMCid:PMC7439008
Trnka P. (2013). Henoch-Schönlein purpura in children. Journal of Paediatrics and Child Health. 49: 995-1003. https://doi.org/10.1111/jpc.12403; PMid:24134307
Varga Z, Flammer AJ, Steiger P et al. (2020) Endothelial cell infection and endotheliitis in COVID-19. Lancet. 395:1417- 1418. https://doi.org/10.1016/S0140-6736(20)30937-5; PMid:32325026
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Modern pediatrics. Ukraine
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The policy of the Journal “MODERN PEDIATRICS. UKRAINE” is compatible with the vast majority of funders' of open access and self-archiving policies. The journal provides immediate open access route being convinced that everyone – not only scientists - can benefit from research results, and publishes articles exclusively under open access distribution, with a Creative Commons Attribution-Noncommercial 4.0 international license (СС BY-NC).
Authors transfer the copyright to the Journal “MODERN PEDIATRICS. UKRAINE” when the manuscript is accepted for publication. Authors declare that this manuscript has not been published nor is under simultaneous consideration for publication elsewhere. After publication, the articles become freely available on-line to the public.
Readers have the right to use, distribute, and reproduce articles in any medium, provided the articles and the journal are properly cited.
The use of published materials for commercial purposes is strongly prohibited.
